&Partners’s Astrana Health ASTH Stock Holding History

&Partners’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$664K	Buy	14,314 +2,618	+22%	+$94.2K	﹤0.01%	1669
2026 Q1	$281K	Buy	11,696 +32	+0.3%	+$758	﹤0.01%	2042
2025 Q4	$289K	Buy	+11,664	New	+$310K	﹤0.01%	1936

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

&Partners's ASTH Position: Q2 2026 in Review

&Partners increased its Astrana Health (ASTH) stake by 22% in Q2 2026, buying an estimated $94.2K and bringing the position to 14,314 shares worth $664K. The position accounts for ﹤0.01% of the portfolio, ranked #1669.

&Partners first reported a position in ASTH in Q4 2025 and has held it in 3 quarters since. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

&Partners held 14,314 shares of Astrana Health worth $664K as of Q2 2026.
&Partners bought 2,618 Astrana Health shares in Q2 2026, an estimated $94.2K.
Astrana Health made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1669 holding.
&Partners first reported a position in Astrana Health in Q4 2025 and has held it in 3 quarters since.
210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.